| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 7 | |
| #2 | Australia | 5 | |
| #3 | Canada | 5 | |
| #4 | United States | 4 | |
| #5 | Republic of Korea | 2 | |
| #6 | Netherlands | 2 | |
| #7 | WIPO (World Intellectual Property Organization) | 2 | |
| #8 | Cyprus | 1 | |
| #9 | Hong Kong | 1 | |
| #10 | Japan | 1 | |
| #11 | Mexico | 1 | |
| #12 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Name | Total Patents |
|---|---|---|
| #1 | Stenzel Wolfgang | 17 |
| #2 | Schotten Theo | 9 |
| #3 | Ruehter Gerd | 7 |
| #4 | Paal Michael | 6 |
| #5 | Armah Ben | 6 |
| #6 | Mest Hans-Juergen | 4 |
| #7 | Armah Ben Dr | 3 |
| #8 | Mest Hans Juergen | 3 |
| #9 | Stenzel Wolfgang Dr | 3 |
| #10 | Mest Hans Jurgen | 2 |
| Publication | Filing date | Title |
|---|---|---|
| US5843938A | Treatment of atherosclerosis | |
| AU7284296A | Treatment of atherosclerosis | |
| EP0766962A2 | Treatment of atherosclerosis | |
| AU4941796A | Use of moxonidine for the treatment of atherosclerosis | |
| EP0628559A1 | Pyrimidine compounds and their use as pharmaceuticals | |
| US5571813A | Fused pyrimidine compounds and their use as pharmaceuticals |